Trial intelligence / Profile preview

Metformin in prepubertal children born small for gestational age with catch-up growth and metabolic risk markers

2009-009944-21Phase 2Active

Sponsor
Sant Joan de Déu Hospital
Start
Mar 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of metformin in cardiometabolic risk (CMR) (2 arms), sponsored by Sant Joan de Déu Hospital. Primary endpoints: Insulin sensitivity, Insulin and 2 more. Started Mar 2009; status: active.

02

Drugs

metformin
03

Conditions

cardiometabolic risk (CMR)

Beyond the preview

Go deeper on 2009-009944-21.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-009944-21.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call